What's Happening?
Khelin Aiken, formerly a counsel at Johnson & Johnson, has joined Baker McKenzie as a partner in their Washington office. Aiken will be part of the firm's transactional practice and healthcare & life sciences team, where she will focus on dealmaking and FDA
regulatory strategy. Her role involves advising life sciences clients on major transactions and navigating the regulatory risks associated with them. Aiken's move marks a return to Baker McKenzie, where she previously served as a partner before taking a regulatory counsel position at Phillip Morris International.
Why It's Important?
Aiken's transition to Baker McKenzie underscores the dynamic nature of legal careers in the healthcare and life sciences sectors. Her expertise in FDA regulatory strategy and dealmaking is particularly valuable as these industries face increasing regulatory scrutiny and complex transactional landscapes. This move could enhance Baker McKenzie's capabilities in advising clients on high-stakes deals, potentially influencing the firm's competitive positioning in the legal market. For Johnson & Johnson, Aiken's departure may prompt a reevaluation of their legal strategies and team composition.
